BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17621)

  • 1. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
    Zimmerman TS; Voss R; Edgington TS
    J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
    Sultan Y; Simeon J; Maisonneuve P; Caen JP
    Thromb Haemost; 1976 Feb; 35(1):110-9. PubMed ID: 1085498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of epinephrine infusion in patients with von Willebrand's disease.
    Rickles FR; Hoyer LW; Rick ME; Ahr DJ
    J Clin Invest; 1976 Jun; 57(6):1618-25. PubMed ID: 1084352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease.
    Casonato A; Sartori MT; Pontara E; Bertomoro A; Dannhäuser D; Girolami
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):567-73. PubMed ID: 1768767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoradiometric measurement of the factor VIII procoagulant antigen.
    Lazarchick J; Hoyer LW
    J Clin Invest; 1978 Nov; 62(5):1048-52. PubMed ID: 81838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
    Montgomery RR; Zimmerman TS
    J Clin Invest; 1978 Jun; 61(6):1498-507. PubMed ID: 307007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
    Green D; Potter EV
    J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand's disease: combined qualitative and quantitative abnormalities.
    Gralnick HR; Sultan Y; Coller BS
    N Engl J Med; 1977 May; 296(18):1024-30. PubMed ID: 300468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the platelet retention factor is separate from the factor VIII-related antigen and factor VIII.
    Rubin H; Alter AA; Walker MR; Stefanyshyn M; Scott L; Miotti AB
    J Lab Clin Med; 1976 Jul; 88(1):14-21. PubMed ID: 180215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Von Willebrand's syndrome (author's transl)].
    Larrieu MJ; Meyer D; Ardaillou N
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):371-82. PubMed ID: 303357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The factor VIII abnormality in severe von Willebrand's disease.
    Zimmerman TS; Abildgaard CF; Meyer D
    N Engl J Med; 1979 Dec; 301(24):1307-10. PubMed ID: 315519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III.
    Lethagen S; Berntorp E; Nilsson IM
    Ann Hematol; 1992 Dec; 65(6):253-9. PubMed ID: 1457586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
    Lethagen S; Harris AS; Nilsson IM
    Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of von Willebrand's disease revisited.
    Bowie EJ; Fass DN; Olson JD; Owen CA
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.